Why Merck Is Betting Big on One Cancer Drug

Merck is making one of the biggest bets on a single drug in the pharmaceutical industry, a move that is risky but that could, if successful, pay off for the company and cancer patients.

from WSJ.com: US Business https://ift.tt/2H3zKmY
via IFTTT